logo

For the Inventor, By the Inventor

Mountainside, NJ, United States of America

Janet C Onishi

This inventor holds 23 USPTO granted patents, primarily in Antifungal Compounds. Top assignee: Merck + Co., Inc.. Active years: 1980-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Janet C Onishi. Retrieved from https://idiyas.com/inventor/janet-c-onishi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23

% Patents Active = 100.0

Average Co-Inventor Count = 2.9

ph-index = 9

Forward Citations = 224(Granted Patents)


Location History:

  • Mountainside, NJ (US) (1980 - 1993)
  • Westfield, NJ (US) (1994 - 1998)

Company Filing History:

goldMedal23 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1980-1998

Loading Chart...
Areas of Expertise:
Antifungal Agents
Squalene Synthetase Inhibitors
HMG-CoA Synthase Inhibitors
Fungicidal Compositions
Mycotic Infections
Antibiotic A43F
Fermentation Products
Antihypercholesterolemic Compounds
23 patents (USPTO):Explore Patents
1. 5821353 - DNA encoding 1,3 beta-D glucan synthase subunits (1998-10-13),
2. 5756472 - Antifungal agent obtained from hormonema (1998-05-26),
3. 5712109 - Antifungal agent produced by arthrinium arundinis ATCC 74359 (1998-01-27),
4. 5597806 - Antifungal agents (1997-01-28),
5. 5348970 - Antifungal compound and compositions containing the compound (1994-09-20),
6. 5214067 - Fungicidal compositions and method (1993-05-25),
7. 5132320 - Squalene synthetase inhibitors (1992-07-21),
8. 5102907 - Novel squalene synthetase inhibitors (1992-04-07),
9. 5096923 - Novel squalene synthetase inhibitors (1992-03-17),
10. 5064856 - Novel HMG-CoA synthase inhibitors (1991-11-12),
11. 5055487 - Novel anti-fungal compounds (1991-10-08),
12. 5053425 - Novel anti-fungal compounds (1991-10-01),
13. 5026554 - Method of inhibiting fungal growth using squalene synthetase inhibitors (1991-06-25),
14. 4988697 - Fungicidal compositions and method (1991-01-29),
15. 4921844 - Fungicidal compositions and method (1990-05-01),

Certainly! Here is the article about inventor Janet C Onishi:

Title: Exploring the Innovative Mind of Inventor Janet C Onishi

Introduction:

Janet C Onishi, a renowned inventor hailing from Mountainside, NJ, has made significant contributions to the field of biotechnology. With an impressive portfolio of 23 patents to her name, Onishi's work has been instrumental in advancing antifungal research and DNA encoding technology.

Latest Patents:

Among her latest patents are groundbreaking innovations such as DNA encoding 1,3 beta-D glucan synthase subunits and an Antifungal agent obtained from hormonema. These patents showcase Onishi's commitment to developing novel compounds with potent antifungal properties, paving the way for innovative solutions in the pharmaceutical industry.

Career Highlights:

Currently affiliated with Merck & Company, Inc., Onishi has thrived in an environment that fosters creativity and scientific discovery. Her tenure at Merck has been marked by a series of breakthroughs, solidifying her reputation as a trailblazer in the field of biopharmaceuticals.

Collaborations:

Throughout her career, Onishi has collaborated closely with esteemed colleagues such as Arthur A Patchett and Jerrold M Liesch. Together, they have synergized their expertise to drive forward ambitious projects and achieve remarkable results in research and development.

Conclusion:

In conclusion, Janet C Onishi's remarkable journey as an inventor exemplifies the power of passion, perseverance, and collaboration in driving innovation forward. Her pioneering work continues to inspire future generations of inventors to push the boundaries of scientific exploration and make meaningful contributions to society.

If you have any more requests or need further assistance, feel free to ask!

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…